awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36628549-7AEB5B67-521B-4116-B46F-4E34F9094302
Q36628549-7AEB5B67-521B-4116-B46F-4E34F9094302
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36628549-7AEB5B67-521B-4116-B46F-4E34F9094302
Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT.
P2860
Q36628549-7AEB5B67-521B-4116-B46F-4E34F9094302
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36628549-7AEB5B67-521B-4116-B46F-4E34F9094302
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c0ccd21505eff9a9ff3b0cc7b43f0b50495a457d
P2860
Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects.